CMS needs to improve oversight of Medicare Part B drug payment calculations, OIG report finds
(By Jakob Emerson for Becker’s Hospital Review ) CMS needs better strategies to ensure proper oversight of Medicare Part B
Read More(By Jakob Emerson for Becker’s Hospital Review ) CMS needs better strategies to ensure proper oversight of Medicare Part B
Read MoreBy Michael McAuliff for Kaiser Health News on December 20, 2022 Doctors are urging Congress to call off cuts scheduled
Read More(Source - www.cms.gov) The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services
Read More(By Rylee Wilson for Becker’s Hospital Review ) CMS is proposing a new rule to streamline options on the ACA
Read More(By Rylee Wilson for Becker’s Hospital Review ) A group of Democratic senators and representatives are concerned about organizations with
Read More(By Fred Schulte and Holly K. Hacker for NPR) In April 2016, government auditors asked a Blue Cross Medicare Advantage
Read More(By Meredith Freed, Tricia Neuman, and Juliette Cubanski for the Kaiser Family Foundation Published: Dec 08, 2022) The 2023 Medicare
Read MoreJapan-based pharmaceutical company Eisai Co., Ltd. recently anno0unced plans to seek full approval for its Alzheimer’s treatment drug lecanemab, a
Read More(By Jeannie Fuglesten Biniek, Nolan Sroczynski, Meredith Freed, and Tricia Neuman for Kaiser Family Foundation Published: Nov 16, 2022) Medicare
Read More(By Rylee Wilson for Becker’s Hospital Review ) CMS wants all traditional Medicare beneficiaries and most Medicaid beneficiaries in accountable
Read More